ABPRO Holdings Inc
NASDAQ:ABP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Donnelley Financial Solutions Inc
NYSE:DFIN
|
US |
EV/OCF
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Valuation Scenarios
If EV/OCF returns to its Industry Average (10.1), the stock would be worth $-8.01 (227% downside from current price).
| Scenario | EV/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | -8 | $6.3 |
0%
|
| Industry Average | 10.1 | $-8.01 |
-227%
|
| Country Average | 16.7 | $-13.19 |
-309%
|
Forward EV/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | EV/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| US |
|
ABPRO Holdings Inc
NASDAQ:ABP
|
74.4m USD | -8 | -0.8 | |
| US |
G
|
GE Vernova LLC
NYSE:GEV
|
303.9B USD | 0 | 0 | |
| UK |
E
|
Eight Capital Partners PLC
F:ECS
|
158.4B EUR | 0 | 0 | |
| US |
C
|
China Industrial Group Inc
OTC:CIND
|
121B USD | 45 425.5 | 4 020.7 | |
| NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
102.5B ZAR | 18.1 | 10.6 | |
| US |
F
|
Fintech Ecosystem Development Corp
NASDAQ:FEXD
|
68.1B USD | -46 040.5 | 38 496.8 | |
| US |
C
|
CoreWeave Inc
NASDAQ:CRWV
|
61.5B USD | 0 | 0 | |
| CH |
G
|
Galderma Group AG
SIX:GALD
|
35.4B CHF | 0 | 0 | |
| US |
|
Symbotic Inc
NASDAQ:SYM
|
38.1B USD | 42.4 | -3 496.4 | |
| US |
|
Coupang Inc
F:788
|
31.7B EUR | 17.9 | 175.5 | |
| US |
R
|
Reddit Inc
NYSE:RDDT
|
31.4B USD | 41.9 | 59.3 |
Market Distribution
| Min | 0 |
| 30th Percentile | 11.7 |
| Median | 16.7 |
| 70th Percentile | 23.6 |
| Max | 3 178 983.5 |
Other Multiples
ABPRO Holdings Inc
Glance View
ABPRO Holdings Inc is a US-based company operating in industry. The company is headquartered in New York City, New York. The company went IPO on 2022-01-14. Abpro Holdings, Inc. is a biotechnology company dedicated to developing next-generation antibody therapeutics, which helps in improving the lives of patients with severe and life-threatening diseases. The firm is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its DiversImmune and MultiMab antibody discovery and engineering platforms, it is engaged in developing a pipeline of antibodies, both independently and through collaborations with global pharmaceutical and research institutions. Its two lead product candidates, ABP-102 and ABP-201, feature its next generation tetravalent antibody format (TetraBi antibody format), which binds to two different targets with two distinct binding sites per target. ABP-102 is designed to redirect a patient’s immune system to fight cancer by engaging T cells through co-targeting human epidermal growth factor receptor 2 (HER2), and cluster of differentiation 3 (CD3), T-cell co-receptor.
